Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Thalidomide metabolites in mice and patients with multiple myelomaJun Lu, Brian D Palmer, Phillip Kestell, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 13, 2004
Metabolism of thalidomide in liver microsomes of mice, rabbits, and humansJun Lu, Nuala Helsby, Brian D Palmer, et al.
Cancer Chemotherapy and Pharmacology|August 31, 2002
Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomideQi Ding, Philip Kestell, Bruce C Baguley, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2006
Antitumour action of 5,6-dimethylxanthenone-4-acetic acid in rats bearing chemically induced primary mammary tumoursJohnson J Liu, Lai-Ming Ching, Michael Goldthorpe, et al.
Oncology Research|December 3, 2003
Effect of 3-fluorothalidomide and 3-methylthalidomide enantiomers on tumor necrosis factor production and antitumor responses to the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Francisco Chung, Brian D Palmer, George W Muller, et al.
Investigational New Drugs|August 13, 2008
Enhancement of the action of the antivascular drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA; ASA404) by non-steroidal anti-inflammatory drugsL-C Steve Wang, Lai-Ming Ching, James W Paxton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Thalidomide pharmacokinetics and metabolite formation in mice, rabbits, and multiple myeloma patientsFrancisco Chung, Jun Lu, Brian D Palmer, et al.
Oncology Research|February 24, 2006
A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell linesSee-Tarn Woon, Charu B Reddy, Catherine J Drummond, et al.
The Lancet. Oncology|March 8, 2003
Antivascular therapy of cancer: DMXAABruce C Baguley
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Tumor stem cell niches: a new functional framework for the action of anticancer drugsBruce C Baguley
Pageof 16